TRIM24 and dermatomyositis: In accordance with a previous study including 312 adult dermatomyositis patients, the pooled sensitivity and specificity of anti-TIF1-γ antibodies to diagnose paraneoplastic dermatomyositis was 78% and 89%, respectively.